Type 2 & other diabetes

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan

Diabetes Res Clin PractPublished Retrospective cross-sectional study

Authors' conclusion

Hypoglycemia-related hospitalization declined in Japan during 2009-2022, with the residual burden remaining concentrated among older adults.

Study context

Population
Patients receiving glucose-lowering medications for T2D, Japanese hospital-based claims data 2009–2022
Participants
1,391,948 patients
Outcome
Hospitalization for hypoglycemia (codes for diagnosis, same-day hospitalization and IV 50% glucose)
Methodological detailshospital-based claims database, modified Poisson regression
  • Hospital-based claims database
  • Modified Poisson regression

Main finding

As reported in the abstract

Hospitalization for hypoglycemia · 2009-2022

Patients hospitalized for hypoglycemia, overall

7,157

Annual frequency in 2009

0.41%

Annual frequency in 2022

0.21%

Observational data: associations, not effects.

Secondary outcomes

Factors associated with all hypoglycemia-related outcomes (hospitalization, nocturnal hospitalization, emergency transport)

Older age and lower BMI were associated with all hypoglycemia-related outcomes
Insulin, pioglitazone, GLP-1 RA, alpha-glucosidase inhibitors and SU were associated with all hypoglycemia-related outcomes

Kidney function (sensitivity analysis)

Impaired kidney function was associated with an increased risk
  • Sensitivity analysis

Original publication

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan. Diabetes Res Clin Pract. Published 27 August 2026. doi:10.1016/j.diabres.2026.113539

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.